Conor Barry

VP Bioconjugates & Biologics Piramal Pharma Solutions

Seminars

Tuesday 4th November 2025
Evaluating Phase & Product Appropriate Bioconjugate Development
12:30 pm
  • Exploring the differing development approaches of ADCs across the preclinical to commercial spectrum
  • Understanding how the bioconjugate landscape now encompasses a wide variety of modalities with differing mechanisms of action and molecular structures
  • Exploring relevant examples of how the requirements for process and analytical development can vary between different conjugates
Conor Barry - 16th World ADC San Diego